Stagezero Life Sciences Ltd(SZLS-T)TSX
StageZero Life Sciences: Top 10 Undervalued Nano Cap Stocks on TSX (SZLS)
StageZero Life Sciences is now ranked among the top 10 nano cap stocks on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below). Nano caps total market capitalization (<50M).
All data provided as-at market close January 19, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. StageZero Life Sciences GeneNews Ltd is focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. StageZero Life Sciences is listed under SZLS on the Toronto Stock Exchange.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| ELEF-T | Silver Elephant Mining | 0.52 | 0 | 0 | 0 | 0 | 0 |
| FLNT-T | FLINT | 0.04 | 0 | 0 | 0 | 0 | 0 |
| BSX-T | Belo Sun Mining | 0.07 | 0 | 0 | 0 | 0 | 0 |
| XLY-T | Auxly Cannabis Group | 0.02 | 0 | 0 | 0 | 0 | 0 |
| TBP-T | Tetra Bio Pharma | 0.03 | 0 | 0 | 0 | 0 | 0 |
| GMTN-T | Gold Mountain Mining | 0.13 | 0 | 0 | 0 | 0 | 0 |
| LPEN-T | Loop Energy | 1.02 | 0 | 0 | 0 | 0 | 0 |
| VIVO-T | VIVO Cannabis | 0.03 | 0 | 0 | 0 | 0 | 0 |
| ASP-T | Acerus Pharmaceuticals | 0.36 | 0 | 0 | 0 | 0 | 0 |
| SZLS-T | StageZero Life Sciences | 0.07 | 0 | 0 | 0 | 0 | 0 |
More about StageZero Life Sciences
Stocks in this category are held primarily for capital appreciation. Nano, micro, and small cap stocks can be very volatile and may generate high returns or losses. Whereas mid and large cap stocks tend to be more stable.
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.